A clear recommendation to emerge from the work on breast cancer is the need for the development of measures specific to the disease and patients themselves.
Few if any of these are specific to breast cancer and may well apply in oncology generally.
Compared with never-users of hormone therapy, current users at the start of the study had an elevated risk of dying of breast cancer (relative risk 1.
Physicians recommend combined hormone therapy mainly to women who still have a uterus, because estrogen-only therapy is associated with an increased risk of endometrial cancer.
Last April, the American Cancer Society (ACS) added more potential cancers when it released the biggest study ever done on excess weight and cancer deaths.
The rapidly expanding American waistline contributes to 14 percent of cancer deaths in men and 20 percent in women, says the ACS.
Her case is among those marking the transition from cancer as a terminal disease to a chronic one.
Metastatic cancer is a returning cancer that spreads primarily into four areas: the brain, lungs, bones and liver.
By simply ratcheting up a tumor's temperature a few degrees--similar to the tiny temperature difference between the testes and the rest of a man's body--scientists are boosting the power of radiation, chemotherapy, and cancer
Budwig who have pursued cancer
remedies and come up with remarkable natural formulas and diets that work for hundreds and thousands of patients.
The Japanese market for cancer
drugs is huge: about JPY526bn (US$4.
New treatment options, solid research and women willing to participate in clinical trials to identify better ways of screening, diagnosing and treating the disease have led to a significant drop in the breast cancer
death rate in recent years, even though the incidence remains about the same.
incidence increased 48 percent between 1950 and 1990, according to the National Cancer
Self-reports, the basis for exposure classification in studies of most known breast cancer
risk factors, are at best a weak method for assessing exposure to many pollutants.
This is the model we are using successfully for our other cancer
drugs, BGC 9331 and BGC 945.